James Nurses Receive Multiple Awards From Oncology Nursing Society

May 01, 2012

COLUMBUS, Ohio – Two nursing professionals at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute will receive awards during the ONS Annual Congress sponsored by the Oncology Nursing Society (ONS).

Research scientist Joanne Lester, who holds a doctorate of philosophy in nursing, is a co-recipient of the 2012 Oncology Nursing Society (ONS) Excellence in Survivor Advocacy Award. She will receive the award May 3 during the Opening Ceremonies of the Annual ONS Congress at the Ernest N. Morial Convention Center in New Orleans. Lester, who is also a certified nurse practitioner and clinical assistant professor in the OSU College of Nursing, is investigating a non-hormonal intervention to relieve vaginal dryness in breast cancer survivors. She is also conducting a study supported by the National Comprehensive Cancer Network (NCCN) to investigate distress experienced by leukemia and breast cancer survivors. Lester, who also is an advanced oncology certified nurse, is the lead editor for a recent ONS book entitled "Cancer Rehabilitation and Survivorship: Transdisciplinary Approaches to Personalized Care."

Gail Davidson, a disease management coordinator in surgical oncology, will receive the 2012 ONS Excellence in Surgical Oncology Award. The ONS annual meeting attracts approximately 3,500 oncology nurses who will learn about cancer care, including survivorship, chemotherapy, symptom management, radiation, patient education and disease management. Davidson is an oncology certified nurse who holds a bachelor's of science in nursing, and practices as a registered nurse. She manages regional liver therapy, neuroendocrine cancers, and gastrointestinal cancers with a focus on improving the quality of life for gastrointestinal cancer patients.

To become a certified oncology nurse, individuals must complete a minimum of one-year experience as an registered nurse, a minimum of 1,000 hours of oncology nursing practice, meet competency requirements, and complete at least 10 hours of continuing education in the field of oncology nursing. ONS is the largest specialty nursing organization with more than 35,000 registered nurses and healthcare providers. Members focus on patient care, education, research and administration with an emphasis on excellence in oncology nursing and quality cancer care.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 210-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report.

###

For a high quality photo of Dr. Lester, click here.

For a high quality photo of Gail Davidson, click here.

Contact: Gretchen Sauer, Medical Center Public Affairs and Media Relations, 614-293-

3737, or Gretchen.Sauer@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations

614-685-5420 (direct)

614-293-3737 (main)

Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

Prostate Cancer Androgen Receptor Activates a Different Gene Set When Bound to Antiandrogens

The androgen receptor in prostate cancer cells can activate different sets of genes depending on whether it binds with an androgen hormone or an antiandrogen drug, according to a new study led by...

Read More

Individualizing Treatments for Multiple Myeloma

This week on Toward a Cancer-Free World, Dr. Craig Hofmeister shares how using an actual virus to help treat certain blood cancer patients may just get us even closer to a cancer-free world.

Read More

Generating New Hope Through Pelotonia-Funded Research

Pelotonia funds support cancer drug development projects at Ohio State. Here’s a brief look at a basic-science study of a targeted agent that may improve cancer-killing virus therapy, and two clinical...

Read More